Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed attachment file name title grouped question UIN question first answered answering member label
tabling member	label

Search

450933

registered interest
date	08/02/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Human Embryo Experiments
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government, further to the Written Answer by Lord Prior of Brampton on 27 January (HL5039), whether they will place in the Library of the House a full copy of the responses to peer reviewers by the person responsible for the recently approved licence application submitted to the Human Fertilisation and Embryology Authority (HFEA) to perform genome editing in human embryos by means of CRISPR-Cas9; to what extent the HFEA’s Executive followed the recommendations raised by both of their peer reviewers; and on how many occasions the HFEA’s Executive have made decisions against the recommendations of all appointed peer reviewers.
tabling member printed	Lord Alton of Liverpool
uin	HL5959
answer	answer is ministerial correction date of answer 11/02/2016 answer text <p>The Human Fertilisation and Embryology Authority (HFEA) publishes on its website the inspection report relating to a licence renewal application and the minutes of the Licence Committee’s decision. It does not publish other information associated with a licence application.</p><p> </p><p>The Human Fertilisation and Embryology Act 1990 (as amended) permits the genetic modification of embryos in research, subject to an HFEA licence. As the regulator, the HFEA’s responsibility is to apply the test in the legislation, namely that the research is necessary or desirable for any of the purposes specified in the Act and that the use of embryos is necessary. The Licence Committee has added a condition to the licence that no research using genome editing may take place until it has received approval from an NHS Research Ethics Committee.</p> answering member printed Lord Prior of Brampton grouped question UIN HL5649 HL5773 HL5960 question first answered 11/02/2016 17:51:32 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	738 label Biography information for Lord Alton of Liverpool

450935

registered interest
date	08/02/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	North Korea: Guided Weapons
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government, further to the Written Answer by Lord Prior of Brampton On 4 February (HL5341), what consideration the NHS has given to offering to share outcome data with test providers, where suitable consents can be captured, on the forthcoming re-procurement of the NHS regional genetics labs, such as from the National Cancer Intelligence Network; and what assessment they have made of the impact of doing so on their procurement process, in the light of the experience of Genomic Enterprise.
tabling member printed	Lord Freyberg
uin	HL5961
answer	answer is ministerial correction date of answer 17/02/2016 answer text <p>The Secretary of State for Foreign and Commonwealth Affairs, my right Hon. Friend the Member for Runnymede and Weybridge (Mr Hammond), strongly condemned the Democratic People’s Republic of Korea (DPRK)’s satellite launch of 7 February, which used ballistic missile technology in clear violation of a number of UN Security Council Resolutions. On 8 February the Minister of State for Foreign and Commonwealth Affairs, my right hon. Friend the Member for East Devon (Mr Swire), summoned the DPRK’s Ambassador to make clear the UK’s strong condemnation of the launch. The DPRK’s actions are a further threat to regional security and the stability of the Korean peninsula. It is clear that the DPRK continues to prioritise its nuclear and ballistic missile programmes over the welfare of its people.</p><p> </p><p>We continue to work closely with other members of the UN Security Council to ensure significant and substantive measures are agreed in response to the DPRK’s provocations. On 8 February the Prime Minister, my right Hon. Friend the Member for Witney (Mr Cameron), and the Foreign Secretary raised this with the Chinese Ambassador and reiterated the need for progress on a new UN Resolution.</p><p> </p><p>We are not part of discussions with the Republic of Korea on a missile defence system, but we respect and support our allies' need to defend themselves.</p> answering member printed Baroness Anelay of St Johns question first answered 17/02/2016 15:04:04 answering member 3474 label Biography information for Baroness Anelay of St Johns
tabling member	2593 label Biography information for Lord Freyberg

450937

registered interest
date	08/02/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	North Korea: Human Rights
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government, further to the Written Answer by Lord Prior of Brampton on 4 February (HL5344), when Genomic England expects to have reported back to patients from the pilot phase on (1) 100 patients, (2) 250 patients, (3) 500 patients, (4) 1000 patients, and (5) all patients.
tabling member printed	Lord Freyberg
uin	HL5963
answer	answer is ministerial correction date of answer 22/02/2016 answer text <p>The existing bilateral programme fund, run by our Embassy in Pyongyang, has contributed to a number of projects aimed at improving the lives of some of the most vulnerable people in the Democratic People’s Republic of Korea (DPRK). These include helping to improve food and nutrition for people in rural areas and equipment for the physically disabled. In addition, our funding of English language projects and visits to the UK for government officials, exposes DPRK citizens to other values and cultures. We assess that many of our existing projects contain a human rights element, without strictly being defined as a human rights project. In the coming year we will continue to fund such projects where possible and will assess future human rights projects under the Magna Carta Fund for Human Rights and Democracy. The amount spent on projects categorised as containing a human rights element between 3 September 2013-8 October 2015 was £270,046.61.</p> answering member printed Earl of Courtown question first answered 22/02/2016 16:26:00 answering member 3359 label Biography information for The Earl of Courtown
tabling member	2593 label Biography information for Lord Freyberg

450938

registered interest
date	08/02/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Financial Services: North Korea
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government, further to the Written Answer by Lord Prior of Brampton on 4 February (HL5345), how many of the 20 patients with reports issued so far by the Genomic England cancer project had (1) a clinically actionable mutation for which the NHS will reimburse the costs of the treatment drug, and (2) a clinically actionable mutation for any trial currently open in the UK; and of those patients in both categories, how many had a clinically actionable mutation in open reading frames that would be covered by a simple next-generation sequencing panel test.
tabling member printed	Lord Freyberg
uin	HL5964
answer	answer is ministerial correction date of answer 22/02/2016 answer text <p>In 2006 the United Nations imposed restrictions on a range of goods from entering or leaving North Korea and imposed a travel ban and asset freeze against those persons designated as persons who engage in or provide support for North Korea’s nuclear-related, other weapons of mass destruction related and ballistic missile-related programmes. These restrictions were implemented in the EU in 2007, and have subsequently been expanded by the EU.</p><p> </p><p>Under the current EU Regulation, UK financial institutions are able to establish banking relationships with North Korean banking institutions if there are no reasonable grounds to believe this will contribute to North Korea’s nuclear-related, other weapons of mass destruction related or ballistic missile-related programmes. In practice, there are almost no financial links between the UK and North Korea. North Korea is almost wholly dependent on China for international assistance.</p><p> </p> answering member printed Lord O'Neill of Gatley question first answered 22/02/2016 17:04:25 answering member 4536 label Biography information for Lord O'Neill of Gatley
tabling member	2593 label Biography information for Lord Freyberg

450944

registered interest
date	08/02/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer: Screening
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what the average waiting time is for a result to be given of a DEXA bone density scan in each NHS region in England; and what assessment they have made of the average waiting time for such results in (1) Scotland, and (2) Wales.
tabling member printed	Baroness Quin
uin	HL5970
answer	answer is ministerial correction date of answer 11/02/2016 answer text <p>Genomics England has set an objective to deliver 8,000 clinical reports by the end of 2016. The precise details of the reports from the pilot and main phases will become clearer once the phenotypic data is collected and linked to the genome data.</p><p> </p> answering member printed Lord Prior of Brampton question first answered 11/02/2016 13:19:44 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	518 label Biography information for Baroness Quin

451110

registered interest
date	08/02/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Management Consultants
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what assessment they have made of whether the intention of NHS Improvement to commission management consultancies to work with turnaround trusts is consistent with their aim to limit the use of such consultancies by NHS organisations.
tabling member printed	Lord Hunt of Kings Heath
uin	HL5976
answer	answer is ministerial correction date of answer 22/02/2016 answer text <p>The guidance for use of management consultancies is set out as part of the spending approvals process. Monitor has published the following guidance for foundation trusts “Consultancy spending approval process: Initial guidance to NHS foundation trusts” with the Trust Development Authority (TDA) publishing similar for NHS trusts “Consultancy spending controls: Initial Guidance to NHS Trusts”. Copies of the guidance are attached.</p><p>The guidance is clear that expenditure on management consultancy must demonstrate that the skills and expertise of advisors cannot be delivered through use of existing resources. It is also a requirement that value for money must be demonstrated. This approach is the same for NHS providers, NHS Improvement or any NHS organisation. Therefore we are content NHS Improvement’s approach to managing turnaround programmes is consistent with this requirement.</p><p> </p><p>NHS Improvement ensures that lessons learned from all financial turnaround programmes are taken into account when considering how to handle any financially challenged providers requiring turnaround actions in the future. This includes the use of the best available, most appropriate consultancies with the right blend of skills and experience required to deliver the turnaround programme.</p><p> </p> answering member printed Lord Prior of Brampton attachment 1 file name Monitor consultancy guidance.pdf title Monitor guidance 2 file name TDA consultancy guidance.pdf title TDA guidance grouped question UIN HL5978 question first answered 22/02/2016 17:07:36 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

451111

registered interest
date	08/02/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Management Consultants
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether they propose to cap the rates paid by NHS bodies to management consultancies, similar to their policy with regard to staff agencies.
tabling member printed	Lord Hunt of Kings Heath
uin	HL5977
answer	answer is ministerial correction date of answer 22/02/2016 answer text <p>Cabinet Office have published guidance on the use of management consultants <em>Cabinet Office controls guidance: version 4.0 </em>which government departments and their arms length bodies are required to follow. A copy of the guidance is attached.</p><p><strong> </strong></p><p>National Health Service providers follow a similar consultancy spending approvals process as defined by Monitor and the Trust Development Authority (TDA). Monitor has published the following guidance for foundation trusts <em>Consultancy spending approval process: Initial guidance to NHS foundation trusts</em>, with TDA publishing similar for NHS trusts <em>Consultancy spending controls: Initial Guidance to NHS Trusts</em>. Copies of the guidance are attached. <br></p><p>At this time, these do not include any directive to set caps on rates paid to management consultancies.</p> answering member printed Lord Prior of Brampton attachment 1 file name Cabinet Office consultancy guidance.pdf title Cabinet Office guidance 2 file name Monitor consultancy guidance.pdf title Monitor guidance 3 file name TDA consultancy guidance.pdf title TDA guidance question first answered 22/02/2016 17:25:18 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

451112

registered interest
date	08/02/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Management Consultants
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether NHS Improvement, in commissioning management consultancies to work with turnaround trusts, will exclude those consultancies which were engaged in any failed initiatives from the previous round of consultancy-driven financial recovery initiatives.
tabling member printed	Lord Hunt of Kings Heath
uin	HL5978
answer	answer is ministerial correction date of answer 22/02/2016 answer text <p>The guidance for use of management consultancies is set out as part of the spending approvals process. Monitor has published the following guidance for foundation trusts “Consultancy spending approval process: Initial guidance to NHS foundation trusts” with the Trust Development Authority (TDA) publishing similar for NHS trusts “Consultancy spending controls: Initial Guidance to NHS Trusts”. Copies of the guidance are attached.</p><p>The guidance is clear that expenditure on management consultancy must demonstrate that the skills and expertise of advisors cannot be delivered through use of existing resources. It is also a requirement that value for money must be demonstrated. This approach is the same for NHS providers, NHS Improvement or any NHS organisation. Therefore we are content NHS Improvement’s approach to managing turnaround programmes is consistent with this requirement.</p><p> </p><p>NHS Improvement ensures that lessons learned from all financial turnaround programmes are taken into account when considering how to handle any financially challenged providers requiring turnaround actions in the future. This includes the use of the best available, most appropriate consultancies with the right blend of skills and experience required to deliver the turnaround programme.</p><p> </p> answering member printed Lord Prior of Brampton attachment 1 file name Monitor consultancy guidance.pdf title Monitor guidance 2 file name TDA consultancy guidance.pdf title TDA guidance grouped question UIN HL5976 question first answered 22/02/2016 17:07:36 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

451113

registered interest
date	08/02/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS Improvement
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government how much money is being spent by NHS Improvement on a re-design of that organisation.
tabling member printed	Lord Hunt of Kings Heath
uin	HL5979
answer	answer is ministerial correction date of answer 11/02/2016 answer text <p>The forecast spend for the design of NHS Improvement is £800,000. This includes the development of a single organisational structure and new operating model to better support the National Health Service to drive improvements.</p> answering member printed Lord Prior of Brampton question first answered 11/02/2016 15:00:39 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

451115

registered interest
date	08/02/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS Low Income Scheme: Students
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government how many university students aged 19 to 25 use the NHS low-income scheme.
tabling member printed	Lord Hunt of Kings Heath
uin	HL5981
answer	answer is ministerial correction date of answer 22/02/2016 answer text <p>73,591 NHS low-income scheme applications were processed in 2015, for England, Scotland and Wales, where the claimant was a student aged between 19 and 25; determined by the age of the main claimant on the date the application was processed. The data may not include students aged 19 - 25 where their partner is the claimant. No distinction is made between a student attending further or higher education.</p><p> </p><p>It is possible that a claimant might submit more than one application annually. A breakdown of the numbers of these applications resulting in full Help with Help Cost support is not available.</p> answering member printed Lord Prior of Brampton question first answered 22/02/2016 16:59:15 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	2024 label Biography information for Lord Hunt of Kings Heath